Target intelligence / Profile preview

Violaxanthin de-epoxidase (VDE) (VDE)

Target
VDE
Molecular classification
Enzyme, Lipocalin-like protein
01

Overview

Violaxanthin de-epoxidase (VDE) is a nuclear-encoded, thylakoid lumen-localized enzyme essential for the photoprotective xanthophyll cycle in plants and algae (UniProt P42520). It is a member of the lipocalin family and is activated when the thylakoid lumen becomes acidic (pH < 6.2) due to high light intensity (Jia et al., 2015, Plant Physiology). VDE catalyzes the conversion of the diepoxide violaxanthin to the epoxide-free zeaxanthin via the intermediate antheraxanthin. Zeaxanthin then interacts with light-harvesting complexes to trigger non-photochemical quenching (NPQ), which safely dissipates excess excitation energy as heat, preventing the formation of singlet oxygen and subsequent photo-oxidative damage (Müller et al., 2001, Plant Physiology). While VDE is not a target for human medicine, it is a primary target in agricultural biotechnology; for instance, accelerating the recovery of NPQ by overexpressing VDE alongside other proteins has been shown to increase crop biomass and yield in fluctuating light conditions (Kromdijk et al., 2016, Science). The enzyme is specifically inhibited by reducing agents such as dithiothreitol (DTT), which prevents the formation of essential disulfide bonds required for its activity (Yamamoto and Kamite, 1972, Biochimica et Biophysica Acta).

Other names
VDEVDE1Violaxanthin-antheraxanthin de-epoxidaseChloroplastic violaxanthin de-epoxidase
02

Mechanism of action

Catalyzes the de-epoxidation of violaxanthin to zeaxanthin via antheraxanthin in response to low lumenal pH; inhibited by reducing agents that disrupt disulfide bonds.

03

Biological functions

Xanthophyll cyclePhotoprotectionNon-photochemical quenching (NPQ)Carotenoid metabolismResponse to high light intensity
04

Disease associations

Photoinhibition (plant)Photo-oxidative stress (plant)Chlorosis
05

Safety considerations

Potential for reduced biomass under low-light conditions if overexpressedIncreased sensitivity to high-light stress in VDE-deficient organismsImpact on carotenoid-derived signaling molecules (e.g., abscisic acid precursors)
06

Interacting drugs

Dithiothreitol (DTT)
07

Biomarkers

Zeaxanthin:Violaxanthin ratioNon-photochemical quenching (NPQ) capacityLumenal pH levels

Beyond the preview

Go deeper on Violaxanthin de-epoxidase (VDE) (VDE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Violaxanthin de-epoxidase (VDE) (VDE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call